Showing results (481-490 of 753) with videos related to
Sort By:
Pageof 76
Cancer|August 27, 2015
Extent of resection and overall survival for patients with atypical and malignant meningiomaAyal A Aizer, Wenya Linda Bi, Manjinder S Kandola, et al.Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2017
Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILEBrian M Alexander, Sujuan Ba, Mitchel S Berger, et al.Cell Reports. Medicine|July 2, 2024
A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)Manmeet S Ahluwalia, Ahmad Ozair, Michelle Rudek, et al.Blood|October 27, 2007
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group reportNancy D Doolittle, Lauren E Abrey, Tamara N Shenkier, et al.Neuroradiology|December 17, 2013
Multimodal MR imaging model to predict tumor infiltration in patients with gliomasChristopher R Durst, Prashant Raghavan, Mark E Shaffrey, et al.Investigational New Drugs|July 14, 2005
Phase II study of CCI-779 in patients with recurrent glioblastoma multiformeSusan M Chang, Patrick Wen, Timothy Cloughesy, et al.Cancer|January 10, 2018
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572David Schiff, Kurt A Jaeckle, S Keith Anderson, et al.Neuro-Oncology|April 24, 2016
Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cellsPítia F Ledur, Chong Liu, Hua He, et al.Pageof 76